Needham & Company LLC restated their buy rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $60.00 target price on the stock. A number of other brokerages also recently weighed in on IONS. Leerink Partnrs raised shares of Ionis Pharmaceuticals from […]

Perion Network (NASDAQ:PERI – Get Free Report)‘s stock had its “hold” rating reiterated by research analysts at Needham & Company LLC in a report released on Thursday,Benzinga reports. Other analysts also recently issued reports about the company. Stifel Nicolaus decreased their target price on Perion Network from $9.00 to $7.50 and set a “hold” rating […]

Needham & Company LLC restated their buy rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research note released on Thursday morning,Benzinga reports. The brokerage currently has a $205.00 target price on the biotechnology company’s stock. Several other research firms have also issued reports on SRPT. Piper Sandler dropped their price target […]

Zillow Group (NASDAQ:Z – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Needham & Company LLC in a note issued to investors on Thursday,Benzinga reports. Several other equities research analysts have also commented on Z. Craig Hallum upgraded shares of Zillow Group to a “strong-buy” rating in a research note […]

Needham & Company LLC reaffirmed their hold rating on shares of Lucid Group (NASDAQ:LCID – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. A number of other research firms have also recently commented on LCID. Cfra set a $2.00 target price on Lucid Group in a research note on Thursday, […]

Needham & Company LLC restated their hold rating on shares of Masimo (NASDAQ:MASI – Free Report) in a research report released on Wednesday morning,Benzinga reports. Several other analysts also recently weighed in on MASI. Raymond James raised shares of Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price target […]